ClinicalTrials.gg
Not yet recruitingNCT06386926Updated Apr 26, 2024

Radial Shockwave Versus Ultrasound Phonophoresis

An interventional study of Electro Therapy in Supraspinatus Tendinitis, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-04-26.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 4 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
69
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Tendinopathy by Cairo University — 4 open to participants now, 4 under way, none of them phase 3. Tendinopathy · Cairo University.

Planned enrollment
Largest of 10
69 · median 50
Started
2024
the only one that year
No phase
10 of 10
4 open now
Registered
5th of 10
by date

Among the 10 studies in Tendinopathy by Cairo University, this one has the largest planned enrollment, is the only one that started in 2024, is one of 10 with no phase, and was the 5th registered.

Tendinopathy

399 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.

Browse Tendinopathy studies →

Open to participants now

4 of the 10 studies in Tendinopathy by Cairo University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 46 Tendinopathy studies recruiting now, 17 (37%) set no upper age limit and 22 (48%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Tendinopathy by Cairo University, or all of them as a file.
02

Study summary

Comparative study to compare the effect of radial shockwave versus ultrasound phonophoresis in management of chronic supraspinatus tendinitis consists of 3 groups exp1(shockwave treatment + conventional physical therapy) , exp2( ultrasound phonophoresis+ conventional physical therapy) and control group ( conventional physical therapy)

03

Conditions studied

  • Supraspinatus Tendinitis

Browse trials for

Keywords

  • Shockwave , phonophoresis , supraspinatus tendinitis
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:- 18.5-24.9

  • 18 years to 60
  • with Unilateral Chronic Supraspinatus Tendinitis.
  • Tenderness is found over the supraspinatus as it passes sub-acrominal and anterolateral.
  • The patient reported with positive Jobe's test (empty can test)
  • The patient reported pain with active shoulder elevation in the scapular plane (eg: welders, plate workers, slaughterhouse workers and overhead playing athletes).
  • The patient reported pain with resisted isometric abduction

Exclusion Criteria:

  • Case reports, treatments after surgery, did not meet our specified outcome parameters, traumatic incidents,
  • Partial tears at surgery
  • Massive retracted tears at surgery
  • Frozen shoulder.
  • Rotator cuff tear.
  • Glenohumeral or acromioclavicular arthritis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
69 participants (estimated)

Study arms

  • Experimental
    Experimental group 1

    23 subjects will Receive radial shockwave by ( Storz Medical /SN:BS.3517 ) for 3 sessions one session per week for four consecutive weeks and conventional physical therapy

    Other: Electro Therapy

  • Experimental
    Experimental group 2

    23 subjects will receive Ultrasound phonophoresis using diclofenac Na+( voltaren) by ( Sonopuls 490 / SN : 36 602 ) for 12 session, 3 sessions per week and same conventional physical therapy

    Other: Electro Therapy

  • Other
    Control group

    23 subjects will receive conventional physical therapy modalities in the for 3 sessions per week for 4 weeks in form of Stretching Exercise in form of exercise of posterior shoulder capsule, strengthening exercises all have been recommended as essential for any shoulder rehabilitation program. These exercise include shoulder flexion, scaption. ,Tens applied for 20 minutes per session using (Enraf Nonius (Endomed 482) SN : 36853 )

    Other: Electro Therapy

Interventions

  • OtherElectro Therapy

    radial shockwave 3 sessions one session per week for four consecutive weeks ,receive Ultrasound phonophoresis using diclofenac Na+ 12 session, 3 sessions per week and conventional physical therapy modalities in the form of 3 sessions every week for 8 weeks

06

What researchers measure

Primary outcomes

  1. change in the thickness of supraspinatus tendon

    Ultrasonography

    Time frame: before start of treatment and 4 weeks following end of treatment

  2. change in pain intesity

    VAS ( visual analog scale score)

    Time frame: before start of treatment and 4 weeks following end of treatment , score from 0-10 ,0=no pain , 10= unbearable pain

  3. Change in shoulder range of motion

    electro goniometer

    Time frame: before start of treatment and 4 weeks following end of treatment

Secondary outcomes

  1. Function of the Upper Limb

    Quick DASH Questionnaire score

    Time frame: before start of treatment and 4 weeks following end of treatment, it measure the disability/symptom section (11 items, scored 1-5)

  2. measure weight in kg and height in cm

    Weight and height scale for determining BMI

    Time frame: before starting the assessment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2024; primary completion for Jul 2024, 2 months later.

Of 174 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 38. This study's planned 2 months is below that.

Counting every sponsor, half of 183 studies reached it within 20 months; a quarter within 7 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 17, 2024
First posted
Apr 26, 2024
StartEst.
May 1, 2024
Primary completionEst.
Jul 2024
CompletionEst.
Sep 2024
Last update
Apr 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06386926
Lead sponsor
Cairo University
Responsible party
Shady Bahaaldin Alkadry (Physical therapist, Cairo University) — Principal investigator
First posted
Apr 26, 2024
Start date
May 1, 2024 (estimated)
Primary completion
Jul 2024 (estimated)
Completion
Sep 2024 (estimated)
Last update
Apr 26, 2024

Study contacts

Shady Alkadry
Contact
shad.bahaa@gmail.com
+201128398533

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion